Mental Health
60 articles on Mental Health, researched and written by the Shotlee Editorial Team from primary sources.
Meghan McCain Responds to 'Old and Ugly' Comments by Rejecting Ozempic
Meghan McCain has publicly pushed back against harsh online comments about her appearance, emphasizing her commitment to natural aging and rejecting the use of weight-loss medications like Ozempic.
6 min read
The Most Confronting Side Effect of Wegovy Weight Loss Wasn't Physical
While physical side effects of Wegovy are well-documented, one patient's experience highlights a profound, non-physical challenge: the shift in how society perceives and treats individuals after significant weight loss.
7 min read
Rosie O'Donnell: Mounjaro Changed My Life After Losing 30kg
Talk show host Rosie O'Donnell discusses her 30kg weight loss using Mounjaro, the subsequent skin concerns, and the mental health benefits of GLP-1 therapy.
6 min read
Rosie O'Donnell: Mounjaro Changed My Life After Losing 30kg
Talk show host Rosie O'Donnell shares her candid experience with Mounjaro, detailing her 30kg weight loss, Type 2 diabetes management, and the physical consequences of rapid fat loss.
12 min read
Amy Schumer Shows Off Ongoing Weight Loss, Says C-Section Scar Makes Her a 'Warrior'
Comedian Amy Schumer discusses her 50-pound weight loss journey, Cushing syndrome diagnosis, and C-section recovery in a candid new update.
10 min read
Anandita Sundar's 7-Year Weight Loss Journey and Body Shaming
Anandita Sundar opens up about her seven-year weight loss journey, highlighting the profound impact of body shaming on mental health and her commitment to prioritizing well-being over societal expectations.
7 min read
Yes, GLP-1s Make You Thinner. But Do They Make You Freer?
While GLP-1 drugs like Ozempic and Wegovy offer significant medical benefits, their rise raises critical questions about freedom, body image, and the cultural pressure to be thinner.
8 min read
Mounjaro's Impact on Food Cravings: A Case Study
A groundbreaking case study involving deep brain activity recordings has shed light on how tirzepatide, known as Mounjaro and Zepbound, impacts the brain's reward center and its connection to food cravings and loss of control eating.
8 min read
Beyond Ozempic: A Dark Twist on Weight Loss Obsession
The rise of GLP-1 agonists has sparked a global conversation about weight loss. This article delves into the cultural phenomenon, its psychological underpinnings, and how a new horror film, 'Saccharine,' offers a chilling commentary.
7 min read
Beyond the Jab: A Natural Weight Loss Journey and Its Hidden Costs
Melanie Sivier chose the 'hard way' over bariatric surgery or new GLP-1 medications like Ozempic and Mounjaro, shedding nine dress sizes through dedication. Her story highlights the profound commitment required for sustainable change, and the often-overlooked physical aftermath.
6 min read
Beyond Weight Loss: How GLP-1s Like Ozempic May Reshape Your Inner World
GLP-1 medications have revolutionized weight loss, but are they also changing how we feel, think, and connect? This article delves into the emerging 'Ozempic Personality' and the science behind potential mood and behavioral shifts.
9 min read
Silencing the Inner Critic: Mastering Food Noise Beyond GLP-1s
The phenomenon of 'food noise'—the constant internal monologue about what, when, and how much to eat—has become a central topic in the age of powerful weight management medications. While GLP-1 agonists are highly effective at dampening this chatter, lasting control often requires integrating behavioral and nutritional strategies. This article explores what food noise is, how medications impact it, and provides a comprehensive guide to regaining mental freedom over your eating habits.
7 min read
Ozempic & Wegovy for Kids? Doctor Warns of Dangers
While GLP-1 medications show promise for adult obesity, their use in children is raising significant concerns. A medical expert weighs in on the potential dangers and the critical need for specialist oversight.
7 min read
Beyond the Scale: How GLP-1s Are Reshaping Women's Social and Career Fortunes
Discover how GLP-1 medications are impacting more than just physical health, influencing career opportunities and personal relationships for women in a remarkable new study.
7 min read
Ozempic, Wegovy, Mounjaro: How Do They Affect Mental Health?
New research sheds light on the neuropsychiatric effects of popular weight loss medications like semaglutide and tirzepatide. Discover how these treatments may influence anxiety, depression, and other mental health outcomes.
7 min read
Wegovy Arrives in Jordan: A New Era for Weight Management
Novo Nordisk has officially launched Wegovy®️ (semaglutide 2.4 mg) in Jordan, marking a significant advancement in the country's approach to tackling the growing challenge of excess weight and its associated health risks.
7 min read
Mounjaro Access Expands: Northern Ireland Launches New Weight Loss Service
Northern Ireland is set to launch a £5 million Regional Obesity Management Service, improving access to Mounjaro and lifestyle support for adults struggling with obesity.
8 min read
Ozempic Culture: Why Medical Weight Loss Needs Better Guardrails
As semaglutide medications become ubiquitous, we must balance their life-saving cardiovascular benefits with the dangers of normalizing extreme thinness and disordered eating behaviors.
7 min read
Ozempic, Wegovy & Mounjaro: Weighing Risks for Young Patients on GLP-1s
As GLP-1 medications gain traction for weight management, doctors are increasingly prescribing them to adolescents. While short-term benefits are evident, significant questions remain about the long-term implications for young, developing bodies and minds.
7 min read
Beyond the Rx: Mastering Metabolic Health with or Without GLP-1s
GLP-1 medications have revolutionized weight loss and diabetes management, but true metabolic health hinges on sustainable lifestyle changes. Discover how to improve your health, with or without these powerful tools.
7 min read
Beyond Hunger: GLP-1s Reveal New Insights into Compulsive Behaviors
Originally developed for diabetes, GLP-1 medications are now revealing profound insights into the neurobiology of desire, reward, and compulsion, impacting everything from food cravings to addictive tendencies.
8 min read
Beyond Weight Loss: GLP-1 Drugs' Surprising Impact on Health
GLP-1 medications, initially developed for diabetes, are revolutionizing health outcomes, offering remarkable benefits for inflammation, joint pain, and even mental outlook, alongside significant weight loss.
8 min read
Beyond the Headlines: New GLP-1 Side Effects Uncovered on Reddit?
A groundbreaking study utilized AI to sift through over 400,000 Reddit posts, uncovering potential new side effects associated with popular GLP-1 medications such as Ozempic, Wegovy, and Mounjaro. This research highlights the growing role of real-world data in understanding medication safety.
8 min read
Beyond Weight Loss: The Expanding Horizon of GLP-1 Therapies
GLP-1 agonists, famously known for Ozempic and Wegovy, are making waves beyond their initial indications. While weight loss and diabetes management remain key, researchers are uncovering a broader therapeutic potential for these powerful peptide therapies.
8 min read
Ozempic & Beyond: Are GLP-1s Shifting America's Obesity Battle?
Once a distant rumor, the idea of widespread obesity in America is now being challenged by a new wave of medications. Discover how GLP-1 drugs are changing the landscape of weight management and what it means for public health.
8 min read
Beyond BMI: Hidden Health Reasons Doctors May Decline Mounjaro or Wegovy
While BMI is a primary factor, a range of underlying health conditions and personal histories can lead to a doctor declining a prescription for popular weight loss medications like Mounjaro and Wegovy. Understanding these criteria is vital before seeking treatment.
7 min read
Beyond Weight Loss: Do GLP-1 Drugs Impact Mental Health?
New research is exploring the surprising potential of GLP-1 receptor agonists, known for their role in diabetes and weight management, to also influence mental well-being. This article delves into the latest findings and what they mean for patients.
7 min read
Beyond Appetite: How GLP-1 Drugs May Be Rewiring the Human Brain
GLP-1 receptor agonists, initially celebrated for revolutionizing diabetes and weight management, are now at the center of an unplanned, massive neuroscience experiment. Emerging data suggests these powerful medications are doing more than just regulating metabolism; they appear to be structurally and functionally altering key brain systems.
7 min read
Beyond BMI: Why Mounjaro Eligibility is More Complex Than You Think
Many assume BMI is the sole determinant for Mounjaro prescriptions, but the reality is far more nuanced. This article explores the comprehensive health criteria healthcare providers use to ensure safe and effective treatment.
6 min read
GLP-1s & Eating Disorders: A Growing Concern for Patients and Doctors
The effectiveness of GLP-1 medications like Ozempic, Wegovy, and Mounjaro for weight loss has led to widespread adoption. However, a concerning trend is emerging: individuals with a history of or current eating disorders are increasingly turning to these drugs, raising alarm bells among healthcare professionals dedicated to eating disorder recovery.
9 min read
Beyond Willpower: Understanding Obesity's Metabolic Roots
Obesity is a complex, multi-organ disease, not a failure of willpower. This article delves into its metabolic underpinnings and outlines a practical approach to management, including modern medications and lifestyle adjustments.
7 min read
GLP-1s for Weight Loss: The NHS Two-Year Limit & Private Costs
As GLP-1 agonists revolutionize weight management, many patients face a critical juncture when NHS funding ends. This article delves into the realities of these powerful medications, the challenges of long-term access, and the growing divide between publicly funded care and private treatment costs.
7 min read
Looksmaxxing: The Risky Trend of Extreme Self-Improvement
Looksmaxxing, a trend focused on extreme self-improvement and physical optimization, has gained significant traction online. While some aspects involve standard grooming and fitness, others venture into dangerous territory, including bone-smashing and unregulated injectable substances. This article delves into the spectrum of looksmaxxing, its psychological underpinnings, and the serious health risks associated with its more extreme practices.
8 min read
Celebrity Weight Loss Transformations: Inspiring Journeys & Modern Approaches
Celebrities often inspire us with their dramatic transformations. This article delves into notable celebrity weight loss stories and explores the evolving landscape of weight management, including the role of new medications and personalized health tracking.
8 min read
Eli Lilly 150 Years: AI, GLP-1 Advances & Future of Weight Loss
Eli Lilly celebrates 150 years with a focus on AI-driven manufacturing, new GLP-1 oral therapies, and expanded neuroscience research, signaling a major shift in pharmaceutical innovation.
8 min read
PCOS Renamed PMOS: A New Era for Endocrine Health
Polycystic Ovary Syndrome (PCOS), a condition affecting millions of women, is undergoing a significant renaming to Polyendocrine Metabolic Ovarian Syndrome (PMOS). This change aims to better reflect the condition's complex interplay with endocrine and metabolic systems, potentially improving diagnosis and treatment.
8 min read
GLP-1 Costs and Rising Spend: Why Primary Care is the New Cost Strategy
With healthcare costs projected to jump another 9% next year, driven significantly by GLP-1 medications like semaglutide and tirzepatide, employers face unprecedented budget pressure. This article explores why reactive cost-cutting fails and how investing upstream in robust primary care coordination is the key to sustainable financial health and better patient outcomes.
6 min read
Navigating Cosmetic Interventions: Ethics, GLP-1s, and Body Autonomy
From GLP-1 medications to plastic surgery, society faces complex questions about beauty, ethics, and medical resources. Discover the balance between empowerment and pressure.
8 min read
GLP-1 Drugs: New Insights into How They Suppress Cravings
A groundbreaking NIH-funded study reveals that emerging GLP-1 weight-loss drugs, including oral options like orforglipron, work by targeting a specific brain reward pathway, distinct from their appetite-suppressing effects. This discovery opens new avenues for understanding and treating conditions beyond weight management.
6 min read
GLP-1 Weight Loss Drugs: The Hidden Social Cost of Success
While GLP-1 medications offer a powerful new path to weight loss, emerging research reveals an unexpected challenge: intensified social stigma. This article explores the nuances of this phenomenon and its implications for patients.
7 min read
Military's $700M GLP-1 Spending: Weight Loss Solutions or Taxpayer Burden?
The U.S. military has spent nearly $726 million on GLP-1 medications since 2021. This article delves into the controversy surrounding this expenditure, examining the obesity crisis within the armed forces and the debate over these weight-loss drugs.
7 min read
GLP-1 Drugs: New Hope for Depression and Motivation?
A recent study published in JAMA Psychiatry has unveiled promising findings regarding GLP-1 receptor agonists, such as semaglutide, and their potential to address a core symptom of major depressive disorder: a lack of motivation. This article delves into the study's methodology, results, and the broader implications for mental health treatment.
8 min read
GLP-1 Drugs: Beyond Weight Loss – New Benefits and Risks Emerge
GLP-1 medications are revolutionizing weight management and diabetes care, but their impact extends far beyond the scale. This article delves into the emerging benefits and potential risks associated with these powerful drugs, offering a comprehensive overview for patients and healthcare providers.
8 min read
Navigating Diet Culture, GLP-1s, and Student Health in Utah
Social media trends and GLP-1 medications are reshaping how Utah students view health. Explore the balance between medical weight management and sustainable habits.
6 min read
Ozempic Personality: Understanding Emotional Changes with GLP-1 Medications
Many users of GLP-1 medications like Ozempic and Wegovy report experiencing 'Ozempic personality,' a phenomenon characterized by emotional flattening and a reduced interest in formerly enjoyable activities. This article delves into what this means, potential causes, and how to navigate these changes.
8 min read
Beyond the Scale: Navigating Weight Loss and Appearance Concerns
Significant weight loss, often achieved with medications like GLP-1 agonists, can bring about transformative health benefits but also raises questions about changes in appearance. This article delves into the phenomenon of 'Mounjaro face,' discusses how to approach sensitive conversations about appearance with friends and family, and offers practical advice for maintaining well-being during and after weight loss.
9 min read
The 'Ozempic Personality': Understanding Emotional Changes with GLP-1s
While GLP-1 medications are celebrated for weight loss and reduced food noise, some users report emotional flattening. This article delves into the 'Ozempic personality' phenomenon, its potential causes, and expert perspectives on managing these psychological shifts.
7 min read
Athlete's Inspiring Weight Loss: A Journey Back to Health and Sport
Kaitlin Hicks, a former athlete, shares her powerful story of overcoming grief-induced weight gain, her health struggles, and her triumphant return to sport after losing a significant amount of weight.
7 min read
Could GLP-1 Medications Cause Anhedonia? Understanding the 'Ozempic Personality' Phenomenon
Is your GLP-1 medication affecting your mood? Discover the science behind anhedonia, the 'Ozempic personality' phenomenon, and what experts say about dopamine and metabolic health.
3 min read
Is 'Ozempic Personality' Real? Mental Health Complaints Examined
Ozempic has transformed weight loss by silencing 'food noise' for many users, but now 'Ozempic personality' is sparking debate. A report highlights mental health complaints during treatment. Is this side effect real, or just hype?
5 min read
Adele's Before & After Pics Highlight 100-Pound Weight Loss
Musician Adele transformed her body in 2020, losing 100 pounds via exercise and a healthy diet amid rising anxiety after her 2019 divorce. Before Ozempic and Mounjaro gained popularity, she focused on building physical and mental strength. Her before-and-after photos and candid interviews reveal a powerful story of self-improvement.
5 min read
Investors' Ozempic Mania Could Harm Health Priorities
Institutional investors have sidelined climate change in ESG priorities, favoring health tech fueled by Ozempic and GLP-1 drugs. A Berenberg Bank survey of 200 investors ranks health first as climate slips to fifth. Yet, climate change poses severe health threats from heatwaves to vector-borne diseases—why this mania could backfire.
4 min read
Taking GLP-1s? Doctors Stress Movement and Mental Health Too
Jelon Smart from Savannah dropped 110 pounds on Ozempic—but credits her intensive workout regimen too. Facing severe ankle swelling from Achilles tendinitis at 285 pounds, she transformed her life. Doctors remind GLP-1 users: movement and mental health are essential alongside medication.
5 min read
New Study: Why Ozempic Works Better for Some Due to Genetics
Ozempic and similar weight-loss drugs like tirzepatide work better for some patients due to specific genetic variants affecting GLP-1 and GIP receptors, a new 23andMe study shows. While average users lose 10% body weight, those with certain gene copies shed up to 1.5kg more—or face higher nausea and vomiting risks. This research uncovers why responses vary widely.
5 min read
Untold Dangers of GLP-1s: Ozempic, Wegovy & Mounjaro Risks
Wegovy, Ozempic, and Mounjaro promise effortless weight loss with minimal risk, but new research uncovers deeper dangers like altered brain chemistry and loss of desire. On The Spectacle Podcast, Scott McKay and Melissa Mackenzie dive into the science, Melissa's personal story, and why lifestyle changes offer a safer path.
5 min read
What to Know If Taking Weight Loss Drugs Like Ozempic
Roughly half a million Australians are using GLP-1 weight loss drugs like Ozempic and Mounjaro, with some reporting life-changing results while others face side effects. Professor Kelly Lambert from the University of Wollongong shares key insights on what you need to know. This guide covers mechanisms, safety, and practical tips for users.
5 min read
Ozempic Users Warned: Don't Skip Exercise, Study Urges
Ozempic users who skip exercise face suboptimal results, according to a new study in Sports Medicine on GLP-1 drugs like Victoza and Saxenda. Among 193 adults, those combining medication with structured workouts saw the best outcomes, while sedentary users fared worst. Meanwhile, one patient's rare blindness side effect highlights ongoing risks.
5 min read
GLP-1 Drugs: Doctors Urge Exercise and Mental Health Too
GLP-1 medications like Ozempic have transformed weight loss for many, but doctors emphasize they're not a standalone solution. Patient Jelon Smart dropped from 285 to 175 pounds only after adding gym workouts to her regimen. Experts stress combining these drugs with movement, smart eating, sleep, and mental health care for long-term success.
5 min read
How Next CDC Director Can Restore America's Public Trust
Five years post-COVID peak, America's trust in the CDC has plummeted amid testing delays, poor communication, and policy missteps. Experts outline six critical reforms for the next director to refocus the agency on infectious threats while addressing chronic diseases. Restoring credibility is essential before the next pandemic strikes.
5 min read
How Layla Taylor Got GLP-1 in Utah: Eating Disorder Warning
Reality star Layla Taylor shares her concerning experience obtaining a GLP-1 prescription with alarming ease in Utah, revealing how the medication became an 'unhealthy crutch' amid her long-term battle with an eating disorder. Her story highlights critical gaps in patient screening and mental health considerations.
7 min read